NO862373D0 - Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.

Info

Publication number
NO862373D0
NO862373D0 NO862373A NO862373A NO862373D0 NO 862373 D0 NO862373 D0 NO 862373D0 NO 862373 A NO862373 A NO 862373A NO 862373 A NO862373 A NO 862373A NO 862373 D0 NO862373 D0 NO 862373D0
Authority
NO
Norway
Prior art keywords
tienopyridones
procedure
preparation
therapeutic active
therapeutic
Prior art date
Application number
NO862373A
Other languages
English (en)
Other versions
NO862373L (no
Inventor
Roy Victor Davies
James Fraser
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO862373D0 publication Critical patent/NO862373D0/no
Publication of NO862373L publication Critical patent/NO862373L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO862373A 1985-06-15 1986-06-13 Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. NO862373L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858515207A GB8515207D0 (en) 1985-06-15 1985-06-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO862373D0 true NO862373D0 (no) 1986-06-13
NO862373L NO862373L (no) 1986-12-16

Family

ID=10580803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862373A NO862373L (no) 1985-06-15 1986-06-13 Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.

Country Status (20)

Country Link
US (1) US4710506A (no)
EP (1) EP0209977A3 (no)
JP (1) JPS6236382A (no)
KR (1) KR870000339A (no)
AU (1) AU581595B2 (no)
CS (1) CS258483B2 (no)
DD (1) DD253823A5 (no)
DK (1) DK272486A (no)
ES (1) ES8707243A1 (no)
FI (1) FI862520A (no)
GB (1) GB8515207D0 (no)
GR (1) GR861527B (no)
HU (1) HU195661B (no)
JO (1) JO1482B1 (no)
NO (1) NO862373L (no)
PH (1) PH22293A (no)
PL (1) PL266392A1 (no)
PT (1) PT82759B (no)
YU (2) YU99386A (no)
ZA (1) ZA864396B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
US4767766A (en) * 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
JP2002522388A (ja) * 1998-08-03 2002-07-23 ビーエーエスエフ コーポレーション 性機能障害の治療のためのピリジノン
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
WO2003000194A2 (en) * 2001-06-21 2003-01-03 Pfizer Inc. Thienopyridine and thienopyrimidine anticancer agents
ES2345438T3 (es) 2002-12-10 2010-09-23 Virochem Pharma Inc. Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus.
JP5247705B2 (ja) * 2006-09-26 2013-07-24 クレストーン・インコーポレーテッド 抗細菌活性を持つ置換チエノピリドン化合物
WO2008039642A2 (en) * 2006-09-26 2008-04-03 Replidyne, Inc. Methods and compounds for treatment of clostridium based infection
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
US7973050B2 (en) * 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US7994192B2 (en) * 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
EA016457B1 (ru) 2006-11-15 2012-05-30 Вирокем Фарма Инк. Аналог тиофена для лечения вирусной инфекции гепатита с

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997545A (en) * 1973-07-23 1976-12-14 Takeda Chemical Industries, Ltd. Thienopyridine-carboxylic acid derivatives
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS5742690A (en) * 1980-08-28 1982-03-10 Kanebo Ltd Thieno 3,2-b pyridinecarboxylic acid derivative
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
JO1482B1 (en) 1988-03-10
DK272486D0 (da) 1986-06-10
GR861527B (en) 1986-10-14
CS436286A2 (en) 1987-12-17
KR870000339A (ko) 1987-02-17
AU5838386A (en) 1986-12-18
PL266392A1 (en) 1988-02-18
DK272486A (da) 1986-12-16
HUT42775A (en) 1987-08-28
ES556026A0 (es) 1987-07-16
YU121187A (en) 1988-04-30
YU99386A (en) 1988-04-30
FI862520A0 (fi) 1986-06-12
EP0209977A3 (en) 1988-06-08
PT82759B (en) 1988-05-12
CS258483B2 (en) 1988-08-16
DD253823A5 (de) 1988-02-03
AU581595B2 (en) 1989-02-23
JPS6236382A (ja) 1987-02-17
NO862373L (no) 1986-12-16
ES8707243A1 (es) 1987-07-16
GB8515207D0 (en) 1985-07-17
EP0209977A2 (en) 1987-01-28
HU195661B (en) 1988-06-28
FI862520A (fi) 1986-12-16
ZA864396B (en) 1987-08-26
US4710506A (en) 1987-12-01
PH22293A (en) 1988-07-22
PT82759A (en) 1986-07-01

Similar Documents

Publication Publication Date Title
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO862956D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO865012L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.